How should a missed period (amenorrhea) be evaluated and managed?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 12, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Evaluation and Management of Missed Period (Amenorrhea)

Rule out pregnancy first with a urine pregnancy test, then proceed with a systematic hormonal evaluation measuring FSH, LH, prolactin, and TSH to categorize the cause and guide treatment. 1, 2

Initial Assessment

Immediate First Step

  • Perform a urine pregnancy test before any other evaluation, as pregnancy is the most common cause of amenorrhea and must be excluded before proceeding 1, 2, 3
  • Modern home pregnancy tests (particularly First Response brand) can detect 97% of pregnancies on the day of missed menses with sensitivity of 5.5 mIU/mL 4

Critical History Elements

  • Document menstrual history: age of menarche, previous cycle regularity, duration of amenorrhea, and last menstrual period 1, 2
  • Assess for functional hypothalamic amenorrhea triggers: weight loss >5% in past 6 months, current BMI, exercise patterns (>10 hours/week intense training warrants evaluation), eating behaviors, and psychosocial stressors 2, 5
  • Screen for hyperandrogenism: hirsutism, acne, androgenetic alopecia 1, 2
  • Evaluate for hyperprolactinemia: galactorrhea, headaches, visual changes 1, 2
  • Review medications: hormonal contraceptives, antipsychotics, antiepileptics, antiretrovirals 6, 5

Physical Examination Priorities

  • Calculate BMI: obesity (>25 kg/m²) suggests PCOS; low BMI (<18.5 kg/m²) suggests functional hypothalamic amenorrhea 2, 5
  • Assess Tanner staging in adolescents to determine pubertal development 2
  • Examine for hyperandrogenism: male-pattern hair distribution, acne, truncal obesity 2, 5
  • Perform nipple expression to detect occult galactorrhea 2

Mandatory Laboratory Testing

First-Line Hormonal Panel

Draw the following labs on any amenorrheic patient after pregnancy is excluded:

  • FSH and LH (draw days 3-6 if cycles present, anytime if amenorrheic): differentiates ovarian failure from hypothalamic/pituitary dysfunction 1, 2, 5
  • Prolactin (single morning resting sample; avoid post-exercise, post-stress, or post-ictal collection): levels >20 μg/L indicate hyperprolactinemia 1, 2, 5
  • TSH: identifies reversible thyroid dysfunction 1, 2, 5
  • Estradiol: levels <30 pg/mL confirm hypoestrogenism characteristic of functional hypothalamic amenorrhea 2, 5

Interpretation Algorithm by FSH Level

Elevated FSH (>35-40 mIU/mL):

  • Indicates primary ovarian insufficiency 1, 2
  • Confirm with repeat FSH 4 weeks later (two elevated values required for diagnosis) 2
  • Order karyotype if age <40 years to detect Turner syndrome or chromosomal abnormalities 2, 5
  • Initiate hormone replacement therapy to prevent osteoporosis and cardiovascular disease 2, 7

Low FSH with Low LH:

  • Indicates hypothalamic or pituitary dysfunction 1, 2
  • LH/FSH ratio <1 seen in 82% of functional hypothalamic amenorrhea cases 2, 5
  • Low estradiol (<30 pg/mL) confirms hypoestrogenism 2, 5
  • Address underlying causes: weight restoration to BMI ≥18.5 kg/m², reduce excessive exercise, nutritional counseling 2

Normal FSH with Elevated LH:

  • LH/FSH ratio >2 strongly suggests PCOS 1, 2, 5
  • Proceed with androgen testing and pelvic ultrasound 1, 2

Additional Testing When Indicated

If hyperandrogenism present (hirsutism, acne):

  • Total testosterone (draw days 3-6): >2.5 nmol/L suggests PCOS; >5 nmol/L warrants tumor evaluation 2, 5
  • Androstenedione: >10.0 nmol/L requires investigation for adrenal/ovarian neoplasm 5
  • DHEA-S: age-adjusted thresholds screen for non-classical congenital adrenal hyperplasia 5

If prolactin elevated:

  • First exclude hypothyroidism by checking TSH 2
  • Order pituitary MRI if prolactin remains elevated or >100 μg/L, or if headaches/visual changes present 2, 5

Imaging Studies

Pelvic Ultrasound Indications

  • LH/FSH ratio >2 (evaluate for polycystic ovarian morphology) 2, 5
  • Clinical features suggesting ovarian pathology 1, 5
  • Assess endometrial thickness: thin (<5 mm) indicates estrogen deficiency; thick (>8 mm) suggests chronic anovulation with unopposed estrogen 2
  • Use transvaginal approach when possible for superior visualization 1, 5

Pituitary MRI Indications

  • Persistent hyperprolactinemia after excluding thyroid disease 2, 5
  • Prolactin >100 μg/L 5
  • Headaches or visual field deficits 2, 5

Management by Etiology

Functional Hypothalamic Amenorrhea

Primary treatment addresses underlying causes:

  • Increase caloric intake to achieve >30 kcal/kg fat-free mass/day 2
  • Reduce exercise volume if >10 hours/week intense training 2
  • Nutritional counseling by sports dietitian 2
  • Recovery may take >6 months despite addressing energy deficits 2

If amenorrhea persists >6 months:

  • Obtain DXA scan for bone mineral density assessment (critical in adolescents as 90% of peak bone mass attained by age 18) 2
  • Initiate transdermal estradiol 100 μg patch twice weekly with cyclic micronized progesterone 200 mg for 12 days/month 2
  • Avoid oral contraceptives as first-line: they mask the problem without addressing energy deficit and don't protect bone density as effectively as physiologic estrogen replacement 2

Polycystic Ovary Syndrome

  • Cyclic progestogen (e.g., medroxyprogesterone 10 mg for 10-14 days monthly) to induce withdrawal bleeding and prevent endometrial hyperplasia 7, 8
  • Combined oral contraceptives for patients desiring contraception or with acne/hirsutism 6, 7
  • Screen for metabolic complications: fasting glucose, lipid panel 8

Hyperprolactinemia

  • Prolactin-lowering drugs (dopamine agonists) for cycle restoration and fertility 7
  • Cyclic progestogen or hormone replacement therapy for cycle disturbance 7
  • Contraceptive pill if contraception needed 7

Primary Ovarian Insufficiency

  • Hormone replacement therapy with estrogen to prevent osteoporosis and cardiovascular disease 2, 7, 8
  • Counsel that unpredictable ovarian function can persist; patients should not be presumed infertile 2, 8

Referral Criteria

Urgent Referral Required

  • No signs of puberty by age 13 years with elevated FSH 2
  • No menarche by age 16 years despite secondary sexual characteristics 2
  • Failure to progress through puberty for ≥12 months 2
  • Prolactin >100 μg/L or any elevation with headaches/visual disturbances 5
  • Testosterone >5 nmol/L or rapid virilization (suggests tumor) 5

Routine Referral Indications

  • Confirmed amenorrhea >6 months 1
  • Abnormal hormone levels suggesting specific pathology 1
  • Signs of hyperandrogenism with menstrual irregularity 1
  • Suspected structural abnormalities on imaging 1
  • Signs of eating disorder or Female Athlete Triad 5

Critical Pitfalls to Avoid

  • Never draw prolactin immediately after seizure, stress, breast examination, or sexual activity; wait 24 hours and obtain morning resting sample 2, 5
  • Do not assume amenorrhea in athletes is benign; exclude other pathology even when clinical picture suggests functional hypothalamic amenorrhea 2
  • Do not prescribe oral contraceptives as first-line for functional hypothalamic amenorrhea; this masks the problem without addressing underlying energy deficit 2
  • Do not overlook eating disorders; adolescents frequently minimize symptoms, requiring direct questioning about specific behaviors 2
  • Do not delay bone density assessment; DXA scanning indicated if amenorrhea extends beyond 6 months regardless of age 2
  • Do not misdiagnose functional hypothalamic amenorrhea with polycystic ovarian morphology as PCOS; check LH/FSH ratio and estradiol (FHA has ratio <1, low estradiol, thin endometrium despite ovarian appearance) 2, 5

References

Guideline

Evaluation of Missed Menstrual Period

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Amenorrhea Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Evaluation of amenorrhea.

American family physician, 1996

Research

The utility of six over-the-counter (home) pregnancy tests.

Clinical chemistry and laboratory medicine, 2011

Guideline

Initial Workup for Irregular Menses (Oligomenorrhea or Amenorrhea)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Related Questions

What is the appropriate evaluation and treatment for a patient with amenorrhea and normal breast development?
What is the next step in management for a 27-year-old woman with amenorrhea (absence of menstruation) for 2 months, negative pregnancy test, normal transvaginal ultrasound, and obesity, with normal laboratory results?
What is the initial workup for a patient presenting with amenorrhea (absence of menstruation)?
What initial laboratory tests should be ordered for a 20-year-old patient (Pt) complaining of amenorrhea (not having a menstrual period) for over a year?
What are the causes of amenorrhea (absence of menstruation)?
How do incomplete, missed, and threatened abortions differ in clinical presentation, ultrasound findings, and management?
Is there a clinically significant drug‑drug interaction between dexlansoprazole (Jemtesa) and quetiapine (Seroquel)?
What glipizide dosing regimen is recommended for an adult patient with an HbA1c of 9.9% and no contraindications?
In a 28‑year‑old woman who experiences intermittent numbness or tingling of the lower limbs when she sits with her legs crossed, which mineral deficiencies should be considered?
What is the next diagnostic test after an abnormal overnight oximetry for suspected obstructive sleep apnea?
In a 42‑year‑old woman who develops shivering, tachycardia, hypertension and severe pain immediately after a total hysterectomy and has received intravenous dexmedetomidine and a loading dose of magnesium sulfate, what are the possible differential diagnoses and how should she be managed?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.